TG Therapeutics (TGTX) Reports Q4 Loss of $0.37/Share

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.37), versus ($0.48) reported last year. Revenue for the quarter came in at $38.1 million, versus $38.1 million reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• AMC Entertainment launches tender offer for $360M in senior notes
• Microchip Technology completes acquisition of Hailo